This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R
NA
This is a hybrid type two study, with two simultaneous development phases. ...
Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure
PHASE2
The goal of this clinical trial is to evaluate whether the drug Loncastuxim...
Status
Recruiting
Location
Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo